Survey on Pharmacy professionals views of thromboprophylaxis in people receiving SACT

Pharmacy professionals views of thromboprophylaxis in people receiving systemic anticancer therapy (SACT) – 5 min survey to inform the development of a clinical trial

Venous thromboembolism (VTE) is a common complication in patients with malignancy, including lung cancer, and is a leading cause of death and morbidity in these patients. However, the role of direct oral anticoagulants (DOACs) for thromboprophylaxis in patients with lung cancer remains uncertain and requires further investigation.

We would be grateful if you could complete a short survey (link below) designed to find out more about pharmacist and pharmacy technician views of this area. Your responses will inform the development of a clinical trial exploring the effectiveness of oral thromboprophylaxis at reducing the rate of venous thromboembolism in people receiving systemic anti-cancer therapy for lung cancer.

https://cardiff.onlinesurveys.ac.uk/antler-trial-lung-cancer-survey-for-pharmacy-professional

This should take no longer than 5 minutes to complete, the deadline for completion is 31-Dec-2023.

We hope BOPA members can be further involved in the development and delivery of the clinical trial and we will keep you updated on progress and opportunities.

 

Thank you for your help,

Prof Alastair Greystoke, Consultant Oncologist, The Newcastle upon Tyne Hospitals NHS Foundation Trust

Dr Kate Musgrave, Consultant Haematologist, The Newcastle upon Tyne Hospitals NHS Foundation Trust

Emma Groves, Lead Pharmacist – Genomic Medicine, NHS North East and Yorkshire Genomic Medicine Service Alliance

Latest News

By BOPA Committee on 12th July 2024

TRANScribing: Clinical considerations for safe and inclusive prescribing for transgender and non-binary patients

BOPA is delighted to announce the publication of TRANScribing: Clinical considerations for safe and inclusive prescribing for transgender and non-binary patients in collaboration with OUTpatients. It is estimated that one…

Read article
By BOPA Committee on 11th July 2024

Round Table Discussion at #BOPA2024

  As an exciting addition to the 2024 conference, we invite you all to participate in one of our interactive sessions on the Sunday morning. We have a lineup of…

Read article
By BOPA Committee on 10th July 2024

APTUK Position Statement for DHSC PGD Update

The Association of Pharmacy Technicians UK (APTUK), as the professional leadership body for pharmacy technicians, welcome the positive outcome of the DHSC consultation supporting the enabling of registered pharmacy technicians…

Read article
By BOPA Research on 9th July 2024

Last Chance to Submit Your Work to #BOPA2024

Last Chance to Submit: BOPA 2024 Abstract Submission DEADLINE is 14th July 2024. Delegates are invited to present results of their clinical and technical work as a poster with some…

Read article